Jeffrey H. Burbank, Chief Executive Officer at NxStage Medical, Inc. (NXTM), sold 3,000 shares at $27.72 ($83K) on 2017-03-21, disclosed to the SEC on 2017-03-22.
Seasonal sale ($83k) by Chief Executive Officer — this insider has traded NXTM in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NXTM | SELL | 2017-03-23 | $82K | — | Filing → |
| NXTM | SELL | 2017-02-24 | $217K | — | Filing → |
| NXTM | SELL | 2017-02-23 | $218K | — | Filing → |